Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H10N4O3 |
| Molecular Weight | 198.1793 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C(=O)NC(N)=C(NC(C)=O)C1=O
InChI
InChIKey=POQOTWQIYYNXAT-UHFFFAOYSA-N
InChI=1S/C7H10N4O3/c1-3(12)9-4-5(8)10-7(14)11(2)6(4)13/h8H2,1-2H3,(H,9,12)(H,10,14)
| Molecular Formula | C7H10N4O3 |
| Molecular Weight | 198.1793 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans. | 2001 Aug |
|
| Validity of an ELISA for N-acetyltransferase-2 (NAT2) phenotyping. | 2001 May 1 |
|
| Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment. | 2001 May 5 |
|
| Stability of 5-acetamido-6-formylamino-3-methyluracil in buffers and urine. | 2002 May 15 |
|
| Extractionless method for the determination of urinary caffeine metabolites using high-performance liquid chromatography coupled with tandem mass spectrometry. | 2003 Jun 15 |
|
| Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study. | 2004 |
|
| Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study. | 2004 |
|
| Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure. | 2004 Mar |
|
| Measurement of caffeine and five of the major metabolites in urine by high-performance liquid chromatography/tandem mass spectrometry. | 2005 Mar |
|
| Concordance between the deduced acetylation status generated by high-speed: real-time PCR based NAT2 genotyping of seven single nucleotide polymorphisms and human NAT2 phenotypes determined by a caffeine assay. | 2007 Feb |
|
| Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected? | 2009 Apr |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:05:01 UTC 2023
by
admin
on
Fri Dec 15 19:05:01 UTC 2023
|
| Record UNII |
R1KU8R8Z0C
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID20173669
Created by
admin on Fri Dec 15 19:05:01 UTC 2023 , Edited by admin on Fri Dec 15 19:05:01 UTC 2023
|
PRIMARY | |||
|
88299
Created by
admin on Fri Dec 15 19:05:01 UTC 2023 , Edited by admin on Fri Dec 15 19:05:01 UTC 2023
|
PRIMARY | |||
|
C054188
Created by
admin on Fri Dec 15 19:05:01 UTC 2023 , Edited by admin on Fri Dec 15 19:05:01 UTC 2023
|
PRIMARY | |||
|
19893-78-8
Created by
admin on Fri Dec 15 19:05:01 UTC 2023 , Edited by admin on Fri Dec 15 19:05:01 UTC 2023
|
PRIMARY | |||
|
R1KU8R8Z0C
Created by
admin on Fri Dec 15 19:05:01 UTC 2023 , Edited by admin on Fri Dec 15 19:05:01 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
|
